Cover of Episode 24 - Selecting and Individualizing PAH Therapy

Episode 24 - Selecting and Individualizing PAH Therapy

Episode 24 - Selecting and Individualizing PAH Therapy

Listen for free

View show details

Season's Savings | 0.99 €/month for 3 months

5.99 €/month thereafter - terms apply. Cancel monthly.

This module explores how risk status, clinical trajectory, right ventricular function, hemodynamics, and patient-specific factors inform the selection and escalation of PAH therapy. It reviews therapies targeting the endothelin, nitric oxide, prostacyclin, and activin signaling pathways and considers how combination therapy and route of administration can be individualized according to disease severity and treatment goals. Particular emphasis is placed on balancing therapeutic efficacy with treatment burden, lifestyle, adherence, support systems, and the patient's ability to manage therapy through shared decision-making.

Visit the link in our bio to earn FREE AMA, ABS, ANCC or ACPE credit!

adbl_web_anon_alc_button_suppression_t1
No reviews yet